ATA4702001A - Verfahren zur herstellung eines impfstoffes - Google Patents

Verfahren zur herstellung eines impfstoffes

Info

Publication number
ATA4702001A
ATA4702001A AT0047001A AT4702001A ATA4702001A AT A4702001 A ATA4702001 A AT A4702001A AT 0047001 A AT0047001 A AT 0047001A AT 4702001 A AT4702001 A AT 4702001A AT A4702001 A ATA4702001 A AT A4702001A
Authority
AT
Austria
Prior art keywords
vaccine
producing
Prior art date
Application number
AT0047001A
Other languages
English (en)
Other versions
AT410636B (de
Original Assignee
Igeneon Krebs Immuntherapie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AT0047001A priority Critical patent/AT410636B/de
Application filed by Igeneon Krebs Immuntherapie filed Critical Igeneon Krebs Immuntherapie
Priority to PL02363720A priority patent/PL363720A1/xx
Priority to US10/472,876 priority patent/US20040191242A1/en
Priority to CA002441499A priority patent/CA2441499A1/en
Priority to JP2002579005A priority patent/JP2004524369A/ja
Priority to BR0208641-7A priority patent/BR0208641A/pt
Priority to SK1173-2003A priority patent/SK11732003A3/sk
Priority to PCT/AT2002/000091 priority patent/WO2002080966A2/de
Priority to CNA028088387A priority patent/CN1522155A/zh
Priority to HU0303638A priority patent/HUP0303638A3/hu
Priority to MXPA03008587A priority patent/MXPA03008587A/es
Priority to EP02706509A priority patent/EP1370289A2/de
Publication of ATA4702001A publication Critical patent/ATA4702001A/de
Application granted granted Critical
Publication of AT410636B publication Critical patent/AT410636B/de
Priority to NO20034145A priority patent/NO20034145L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT0047001A 2001-03-23 2001-03-23 Verfahren zur herstellung eines impfstoffes AT410636B (de)

Priority Applications (13)

Application Number Priority Date Filing Date Title
AT0047001A AT410636B (de) 2001-03-23 2001-03-23 Verfahren zur herstellung eines impfstoffes
CNA028088387A CN1522155A (zh) 2001-03-23 2002-03-20 生产疫苗的方法
CA002441499A CA2441499A1 (en) 2001-03-23 2002-03-20 Method for producing a vaccine
JP2002579005A JP2004524369A (ja) 2001-03-23 2002-03-20 ワクチンの製造方法
BR0208641-7A BR0208641A (pt) 2001-03-23 2002-03-20 Método para produzir uma vacina contendo anticorpos autólogos e uso da mesma
SK1173-2003A SK11732003A3 (sk) 2001-03-23 2002-03-20 Spôsob výroby očkovacej látky
PL02363720A PL363720A1 (en) 2001-03-23 2002-03-20 Method for producing a vaccine
US10/472,876 US20040191242A1 (en) 2001-03-23 2002-03-20 Method for producing a vaccine
HU0303638A HUP0303638A3 (en) 2001-03-23 2002-03-20 Method for producing a vaccine
MXPA03008587A MXPA03008587A (es) 2001-03-23 2002-03-20 Metodo para producir una vacuna.
EP02706509A EP1370289A2 (de) 2001-03-23 2002-03-20 Verfahren zur herstellung eines autologen antikörpers enthaltenden impfstoffes
PCT/AT2002/000091 WO2002080966A2 (de) 2001-03-23 2002-03-20 Verfahren zur herstellung eines autologen antikörpers enthaltenden impfstoffes
NO20034145A NO20034145L (no) 2001-03-23 2003-09-17 Fremgangsmåte til å produsere en vaksine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0047001A AT410636B (de) 2001-03-23 2001-03-23 Verfahren zur herstellung eines impfstoffes

Publications (2)

Publication Number Publication Date
ATA4702001A true ATA4702001A (de) 2002-11-15
AT410636B AT410636B (de) 2003-06-25

Family

ID=3674741

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0047001A AT410636B (de) 2001-03-23 2001-03-23 Verfahren zur herstellung eines impfstoffes

Country Status (13)

Country Link
US (1) US20040191242A1 (de)
EP (1) EP1370289A2 (de)
JP (1) JP2004524369A (de)
CN (1) CN1522155A (de)
AT (1) AT410636B (de)
BR (1) BR0208641A (de)
CA (1) CA2441499A1 (de)
HU (1) HUP0303638A3 (de)
MX (1) MXPA03008587A (de)
NO (1) NO20034145L (de)
PL (1) PL363720A1 (de)
SK (1) SK11732003A3 (de)
WO (1) WO2002080966A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT410637B (de) * 2001-06-01 2003-06-25 Igeneon Krebs Immuntherapie Verwendung von polyklonalen immunglobulinen
WO2005090403A2 (en) * 2004-03-12 2005-09-29 Biovest International, Inc. Method and apparatus for antibody purification
EP2471957A1 (de) * 2007-02-21 2012-07-04 Oslo Universitetssykehus HF Neue Krebsmarker
EP2236520A1 (de) * 2009-03-31 2010-10-06 Leukocare Ag Stabilisierungszusammensetzung für immobilisierte Biomoleküle
WO2022103871A1 (en) * 2020-11-10 2022-05-19 Wyomingv Immune, Inc. Therapeutic compositions for the treatment of covid-19
CN114887047A (zh) * 2022-06-21 2022-08-12 苏州工业园区唯可达生物科技有限公司 基于ny-eso-1肿瘤抗原的疫苗及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4436558A1 (de) * 1994-10-13 1996-04-18 Vitorgan Arzneimittel Gmbh Verfahren zur Herstellung von humanen Impfstoffen gegen allergieauslösende Substanzen
AU705010B2 (en) * 1994-11-16 1999-05-13 Arizona Board Of Regents On Behalf Of The University Of Arizona, The Human antibodies to t-cell receptor peptides and methods for their preparation
DE19538641C2 (de) * 1995-10-05 2000-09-21 Privates Inst Bioserv Gmbh Patientenspezifische Immunadsorber für die extrakorporale Apherese und Verfahren für deren Herstellung
WO1998026086A1 (en) * 1996-12-11 1998-06-18 University Of Florida Novel methods and compositions for treatment of autoimmune diseases
US7022036B2 (en) * 2003-05-21 2006-04-04 Prototoy Llc Electronic throw-and-catch game

Also Published As

Publication number Publication date
NO20034145D0 (no) 2003-09-17
EP1370289A2 (de) 2003-12-17
PL363720A1 (en) 2004-11-29
HUP0303638A3 (en) 2004-10-28
SK11732003A3 (sk) 2004-03-02
CA2441499A1 (en) 2002-10-17
AT410636B (de) 2003-06-25
WO2002080966A3 (de) 2003-09-12
BR0208641A (pt) 2004-03-09
US20040191242A1 (en) 2004-09-30
HUP0303638A2 (hu) 2004-01-28
NO20034145L (no) 2003-11-07
MXPA03008587A (es) 2004-06-30
WO2002080966A2 (de) 2002-10-17
JP2004524369A (ja) 2004-08-12
WO2002080966A8 (de) 2003-01-23
CN1522155A (zh) 2004-08-18

Similar Documents

Publication Publication Date Title
DE60201421D1 (de) Verfahren zur herstellung eines wachsartigen raffinats
ATA10622000A (de) Verfahren zur herstellung eines haarstreifens
DE60212183D1 (de) Verfahren zur herstellung eines verbundes
DE50303605D1 (de) Verfahren zur herstellung eines pressgehärteten bauteils
DE60224265D1 (de) Verfahren zur herstellung eines mit flanschen versehenen formteils
DE50302301D1 (de) Verfahren zur herstellung eines formteiles
DE60022857D1 (de) Verfahren zur Herstellung eines Halbleiterbauelements
DE60230272D1 (de) Verfahren zur herstellung eines viskoelastischen schaumstoffs
DE60328461D1 (de) Verfahren zur herstellung eines chinazolin-4-onderivats
ATE414058T1 (de) Verfahren zur herstellung eines sulfinyl- acetamids
DE50113179D1 (de) Verfahren zur Herstellung eines Halbleiterbauelements
DE60222896D1 (de) Verfahren zur herstellung eines polyurethan-weichschaumstoffs
DE60143315D1 (de) Verfahren zur herstellung eines fermentierten getränks
DE60044470D1 (de) Verfahren zur herstellung eines halbleiterelement
DE60205676D1 (de) Verfahren zur Herstellung eines Gegenstandes
ATE466016T1 (de) Verfahren for zur herstellung eines 14- hydroxynormorphinon-derivats
DE60100708D1 (de) Verfahren zur herstellung eines titanhaltigen zeolithen
DE60212643D1 (de) Verfahren zur herstellung eines reifenkomponentenglieds
DE60317715D1 (de) Verfahren zur herstellung eines sektionaltorpaneels
DE50212805D1 (de) Verfahren zur Herstellung eines Querträgers
DE50304619D1 (de) Verfahren zur herstellung eines bauteils
DE50115727D1 (de) Piezoaktor und verfahren zur herstellung eines piezoaktors
DE60230982D1 (de) Verfahren zur herstellung eines halbleiterbauelements
DE60140362D1 (de) Verfahren zur herstellung eines halbleiterbauelements
DE60209835D1 (de) Verfahren zur Herstellung eines Halbleiterbauelements

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
ELJ Ceased due to non-payment of the annual fee